Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Developed by Novo Nordisk, WEGOVY (semaglutide) is a GLP-1 receptor agonist designed to support sustainable weight loss when paired with a balanced diet and regular physical activity
The decrease in the size of thyroid nodules may result from supplementation with extracts of plants with antioxidant and anti-inflammatory properties (93)
CAUTION: Formulated for adults and children four years and older
More than half of patients prescribed semaglutide or liraglutide for all treatment durations studied were able to maintain or continue their weight loss one year after treatment
US$ 25.79
US$ 24.38
US$ 24.92
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 25.05
US$ 29.47
US$ 29.29
